Menu
Recruiting NCT06486233

Studying the Effectiveness of Early Invasive Treatment in Elderly Patients With High-risk Non-ST-segment Elevation Acute Coronary Syndrome.

Observational Myocardial Infarction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Myocardial Infarction. Basic parameters: from 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Vietnam
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Comparison of Mortality and Complication Rates (Re-myocardial Infarction, Heart Failure, Re-hospitalization, Stroke) After 12 Months Between Two Groups of Patients Undergoing Early Invasive and Late Invasive Strategies in Patients With Elderly Patients With High - Risk Non-ST-segment Elevation Acute Coronary Syndrome.

Overview

The goal of this is observational study is to compare about MACE events and predisposing factors related to MACE events in elderly patients with high-risk non-ST acute coronary syndromes receiving early versus late invasive treatment . This study will anwser two questions. Question 1: What will factors associate with implementing a late invasive strategy in elderly patients with high-risk non-ST-segment elevation acute coronary syndrome ? Question 2: Is a meaningful difference about mortality and complication rates as re-myocardial infarction, heart failure, re-hospitalization, stroke after 12 months between two groups of patients undergoing early invasive and late invasive strategies in elderly patients with in high-risk non-ST-segment elevation acute coronary syndrome?

Primary outcome measures

  • In-hospital death [Time frame: one month]
Secondary outcome measures (2)
  • after 12 months death [Time frame: one year]
  • MACE after 12 months include re-admission, recurrent myocardial infarction , stroke, heart failure [Time frame: one year]

Eligibility criteria

Inclusion criteria

  • aged 60 years and older
  • high - risk non-ST-segment elevation acute coronary syndrome (according to the 2023 European Heart Association recommended standards).
  • receives reperfusion intervention.

Exclusion criteria

  • Acute coronary syndrome due to stent thrombosis, or coronary artery bypass graft occlusion.
  • Incomplete medical records.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Vietnam · 1 center
  • Gia Dinh people hospital — Ho Chi Minh City

Identifiers

NCT: NCT06486233 · 329/HDDD-DHYD

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗